Nutrien Ltd. (NYSE:NTR) Shares Sold by Candriam S.C.A.

Candriam S.C.A. decreased its holdings in shares of Nutrien Ltd. (NYSE:NTRFree Report) by 6.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,646 shares of the company’s stock after selling 571 shares during the quarter. Candriam S.C.A.’s holdings in Nutrien were worth $387,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Lindbrook Capital LLC raised its stake in Nutrien by 50.6% during the fourth quarter. Lindbrook Capital LLC now owns 1,247 shares of the company’s stock worth $56,000 after acquiring an additional 419 shares during the period. Assetmark Inc. raised its stake in Nutrien by 1,437.5% during the fourth quarter. Assetmark Inc. now owns 738 shares of the company’s stock worth $33,000 after acquiring an additional 690 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Nutrien by 8.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,886,376 shares of the company’s stock worth $84,367,000 after acquiring an additional 144,025 shares during the period. Steward Partners Investment Advisory LLC raised its stake in Nutrien by 11.2% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 4,736 shares of the company’s stock worth $212,000 after acquiring an additional 477 shares during the period. Finally, SBI Securities Co. Ltd. acquired a new stake in Nutrien during the fourth quarter worth about $418,000. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Trading Down 1.1 %

Nutrien stock opened at $50.54 on Tuesday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The firm has a market cap of $24.73 billion, a price-to-earnings ratio of 36.89, a price-to-earnings-growth ratio of 1.19 and a beta of 0.81. Nutrien Ltd. has a 1 year low of $43.70 and a 1 year high of $60.87. The firm’s 50 day moving average price is $50.84 and its two-hundred day moving average price is $48.61.

Nutrien (NYSE:NTRGet Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.09). The business had revenue of $5.08 billion during the quarter, compared to analyst estimates of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. On average, research analysts predict that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.

Nutrien Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Shareholders of record on Monday, March 31st will be given a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 4.31%. The ex-dividend date of this dividend is Monday, March 31st. Nutrien’s payout ratio is 159.12%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Wells Fargo & Company raised their price target on shares of Nutrien from $53.00 to $56.00 and gave the company an “equal weight” rating in a research note on Friday, February 21st. Scotiabank raised their price target on shares of Nutrien from $60.00 to $62.00 and gave the company a “sector outperform” rating in a research note on Monday, February 24th. CIBC raised their price target on shares of Nutrien from $64.00 to $66.00 and gave the company an “outperformer” rating in a research note on Tuesday, February 25th. Royal Bank of Canada restated an “outperform” rating and issued a $60.00 price target on shares of Nutrien in a research note on Monday, February 24th. Finally, Piper Sandler raised their price target on shares of Nutrien from $58.00 to $63.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $60.13.

Get Our Latest Stock Analysis on Nutrien

Nutrien Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Articles

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.